Shingrix Vaccine’s Risk of Guillain-Barré Syndrome Results in New FDA Warning
The Shingrix vaccine, used to prevent shingles, may increase the risk of Guillain-Barre Syndrome, which can cause muscle weakness and paralysis, the FDA warns.…
«
»
The Shingrix vaccine, used to prevent shingles, may increase the risk of Guillain-Barre Syndrome, which can cause muscle weakness and paralysis, the FDA warns.…
The first three bellwether Zostavax cases should be ready for trial by late September, according to a schedule released by the court.…
A second group of Zostavax lawsuits have been selected to be the basis for a second batch of bellwether trials over the side effects of the shingles vaccine.…
A new Zostavax lawsuit claims the shingles vaccine can cause vision loss and loses potency over time.…
A federal judge has ordered two groups of Zostavax cases prepared for bellwether trials in 2021 and 2022.…
The first Zostavax bellwether trial is scheduled for November 2021, involving claims the shingles vaccine can actually cause shingles and other ailments.…
A Zostavax lawsuit indicates the side effects of the vaccine caused the very shingles it was supposed to prevent.…
A Zostavax lawsuit claims side effects of the vaccine caused brain hemorrhaging, while the federal legislation has been temporarily put on hold.…
A Zostavax lawsuit claims the side effects of the shingles vaccine resulted in hearing loss. …
A Zostavax lawsuit claims the shingles vaccine caused a man to suffer postherpetic neuralgia, a condition associated with the very disease the vaccine was supposed to prevent.…